Fred Kamal occupies the position of Chief Operating & Technical Officer at 4D Molecular Therapeutics, Inc.

In the past Dr. Kamal occupied the position of Vice President-Quality & Regulatory CMC at InterMune, Inc., Vice President-Quality at Juno Therapeutics, Inc. and Senior Vice President-Quality & Regulatory CMC at Novartis Gene Therapies, Inc.

Fred Kamal received an undergraduate degree from San Jose State University and a graduate degree and a doctorate from American University.